IBDEI0AZ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4780,0)
 ;;=244.9^^23^242^64
 ;;^UTILITY(U,$J,358.3,4780,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4780,1,4,0)
 ;;=4^244.9
 ;;^UTILITY(U,$J,358.3,4780,1,5,0)
 ;;=5^HYPOTHYROIDISM NOS
 ;;^UTILITY(U,$J,358.3,4781,0)
 ;;=246.9^^23^242^95
 ;;^UTILITY(U,$J,358.3,4781,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4781,1,4,0)
 ;;=4^246.9
 ;;^UTILITY(U,$J,358.3,4781,1,5,0)
 ;;=5^THYROID DISEASE
 ;;^UTILITY(U,$J,358.3,4782,0)
 ;;=564.5^^23^242^41
 ;;^UTILITY(U,$J,358.3,4782,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4782,1,4,0)
 ;;=4^564.5
 ;;^UTILITY(U,$J,358.3,4782,1,5,0)
 ;;=5^DIARRHEA, FUNCTIONAL
 ;;^UTILITY(U,$J,358.3,4783,0)
 ;;=733.00^^23^242^82
 ;;^UTILITY(U,$J,358.3,4783,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4783,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,4783,1,5,0)
 ;;=5^OSTEOPOROSIS NOS
 ;;^UTILITY(U,$J,358.3,4784,0)
 ;;=009.2^^23^242^42
 ;;^UTILITY(U,$J,358.3,4784,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4784,1,4,0)
 ;;=4^009.2
 ;;^UTILITY(U,$J,358.3,4784,1,5,0)
 ;;=5^DIARRHEA, INFECTIOUS
 ;;^UTILITY(U,$J,358.3,4785,0)
 ;;=562.10^^23^242^44
 ;;^UTILITY(U,$J,358.3,4785,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4785,1,4,0)
 ;;=4^562.10
 ;;^UTILITY(U,$J,358.3,4785,1,5,0)
 ;;=5^DIVERTICULOSIS OF COLON
 ;;^UTILITY(U,$J,358.3,4786,0)
 ;;=455.6^^23^242^61
 ;;^UTILITY(U,$J,358.3,4786,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4786,1,4,0)
 ;;=4^455.6
 ;;^UTILITY(U,$J,358.3,4786,1,5,0)
 ;;=5^HEMORRHOIDS NOS
 ;;^UTILITY(U,$J,358.3,4787,0)
 ;;=413.9^^23^242^4
 ;;^UTILITY(U,$J,358.3,4787,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4787,1,4,0)
 ;;=4^413.9
 ;;^UTILITY(U,$J,358.3,4787,1,5,0)
 ;;=5^ANGINA PECTORIS NEC/NOS
 ;;^UTILITY(U,$J,358.3,4788,0)
 ;;=564.1^^23^242^73
 ;;^UTILITY(U,$J,358.3,4788,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4788,1,4,0)
 ;;=4^564.1
 ;;^UTILITY(U,$J,358.3,4788,1,5,0)
 ;;=5^IRRITABLE COLON
 ;;^UTILITY(U,$J,358.3,4789,0)
 ;;=414.8^^23^242^26
 ;;^UTILITY(U,$J,358.3,4789,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4789,1,4,0)
 ;;=4^414.8
 ;;^UTILITY(U,$J,358.3,4789,1,5,0)
 ;;=5^CHR ISCHEMIC HRT DIS NEC
 ;;^UTILITY(U,$J,358.3,4790,0)
 ;;=786.50^^23^242^24
 ;;^UTILITY(U,$J,358.3,4790,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4790,1,4,0)
 ;;=4^786.50
 ;;^UTILITY(U,$J,358.3,4790,1,5,0)
 ;;=5^CHEST PAIN NOS
 ;;^UTILITY(U,$J,358.3,4791,0)
 ;;=596.59^^23^242^12
 ;;^UTILITY(U,$J,358.3,4791,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4791,1,4,0)
 ;;=4^596.59
 ;;^UTILITY(U,$J,358.3,4791,1,5,0)
 ;;=5^BLADDER DYSFUNCTION
 ;;^UTILITY(U,$J,358.3,4792,0)
 ;;=427.31^^23^242^10
 ;;^UTILITY(U,$J,358.3,4792,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4792,1,4,0)
 ;;=4^427.31
 ;;^UTILITY(U,$J,358.3,4792,1,5,0)
 ;;=5^ATRIAL FIBRILLATION
 ;;^UTILITY(U,$J,358.3,4793,0)
 ;;=427.9^^23^242^21
 ;;^UTILITY(U,$J,358.3,4793,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4793,1,4,0)
 ;;=4^427.9
 ;;^UTILITY(U,$J,358.3,4793,1,5,0)
 ;;=5^CARDIAC DYSRHYTHMIA NOS
 ;;^UTILITY(U,$J,358.3,4794,0)
 ;;=424.1^^23^242^6
 ;;^UTILITY(U,$J,358.3,4794,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4794,1,4,0)
 ;;=4^424.1
 ;;^UTILITY(U,$J,358.3,4794,1,5,0)
 ;;=5^AORTIC VALVE DISORDER
 ;;^UTILITY(U,$J,358.3,4795,0)
 ;;=428.0^^23^242^37
 ;;^UTILITY(U,$J,358.3,4795,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4795,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,4795,1,5,0)
 ;;=5^CONGESTIVE HEART FAILURE
 ;;^UTILITY(U,$J,358.3,4796,0)
 ;;=791.0^^23^242^90
 ;;^UTILITY(U,$J,358.3,4796,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4796,1,4,0)
 ;;=4^791.0
 ;;^UTILITY(U,$J,358.3,4796,1,5,0)
 ;;=5^PROTEINURIA
 ;;
 ;;$END ROU IBDEI0AZ
